Taylor Morrison Home
TMHC
D.R. Horton
DHI
Adobe
ADBE
4
Meritage Homes
MTH
5
Meta Platforms
META
US Stock MarketDetailed Quotes
ALXO ALX Oncology
- 0.749
- -0.023-3.01%
Close Mar 20 16:00 ET
- 0.750
- +0.002+0.20%
Post 17:23 ET
39.96MMarket Cap-0.29P/E (TTM)
0.783High0.731Low315.64KVolume0.770Open0.772Pre Close237.68KTurnover0.98%Turnover RatioLossP/E (Static)53.38MShares17.82552wk High0.35P/B24.21MFloat Cap0.73152wk Low--Dividend TTM32.34MShs Float117.450Historical High--Div YieldTTM6.75%Amplitude0.731Historical Low0.753Avg Price1Lot Size
ALX Oncology Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -16.33%142.47M | -36.25%30.61M | -38.87%32.57M | 12.91%41.53M | 17.26%37.76M | 33.62%170.28M | 49.05%48.02M | 45.24%53.28M | 8.84%36.78M | 30.13%32.2M |
| Selling and administrative expenses | -8.39%26.09M | 13.50%7.08M | -18.82%6.1M | -5.80%6.87M | -18.75%6.05M | -1.90%28.48M | -11.15%6.24M | 2.88%7.51M | 3.61%7.3M | -3.05%7.44M |
| -General and administrative expense | -8.39%26.09M | 13.50%7.08M | -18.82%6.1M | -5.80%6.87M | -18.75%6.05M | -1.90%28.48M | -11.15%6.24M | 2.88%7.51M | 3.61%7.3M | -3.05%7.44M |
| Research and development costs | -17.93%116.37M | -43.68%23.53M | -42.16%26.47M | 17.54%34.65M | 28.08%31.72M | 44.10%141.8M | 65.83%41.78M | 55.76%45.77M | 10.22%29.48M | 45.04%24.76M |
| Operating profit | 16.33%-142.47M | 36.25%-30.61M | 38.87%-32.57M | -12.91%-41.53M | -17.26%-37.76M | -33.62%-170.28M | -49.05%-48.02M | -45.24%-53.28M | -8.84%-36.78M | -30.13%-32.2M |
| Net non-operating interest income expense | -15.93%7.64M | -43.76%1.45M | -18.77%1.86M | -6.97%2.13M | 14.09%2.2M | 124.85%9.08M | 63.71%2.58M | 67.11%2.29M | 162.47%2.29M | 766.67%1.92M |
| Non-operating interest income | -12.05%9.37M | -37.30%1.88M | -13.97%2.3M | -3.86%2.56M | 13.46%2.62M | 148.92%10.65M | 65.74%3M | 95.40%2.68M | 204.34%2.67M | 927.11%2.31M |
| Non-operating interest expense | 10.48%1.73M | 2.89%427K | 14.07%446K | 15.32%429K | 10.34%427K | 557.56%1.57M | 79.65%415K | 19,450.00%391K | 18,500.00%372K | 12,800.00%387K |
| Other net income (expense) | -105.14%-20K | 96.55%-1K | 400.00%3K | -102.47%-8K | -114.74%-14K | 1,868.18%389K | -1,350.00%-29K | 85.71%-1K | 6,580.00%324K | 1,287.50%95K |
| Other non- operating income (expenses) | -105.14%-20K | 96.55%-1K | 400.00%3K | -102.47%-8K | -114.74%-14K | 1,868.18%389K | -1,350.00%-29K | 85.71%-1K | 6,580.00%324K | 1,287.50%95K |
| Income before tax | 16.14%-134.85M | 35.87%-29.16M | 39.78%-30.71M | -15.34%-39.4M | -17.88%-35.58M | -30.29%-160.81M | -48.38%-45.47M | -44.37%-50.99M | -3.76%-34.16M | -23.03%-30.18M |
| Income tax | 0 | 0 | ||||||||
| Net income | 16.14%-134.85M | 35.87%-29.16M | 39.78%-30.71M | -15.34%-39.4M | -17.88%-35.58M | -30.23%-160.81M | -48.07%-45.47M | -44.37%-50.99M | -3.76%-34.16M | -23.03%-30.18M |
| Net income continuous Operations | 16.14%-134.85M | 35.87%-29.16M | 39.78%-30.71M | -15.34%-39.4M | -17.88%-35.58M | -30.23%-160.81M | -48.07%-45.47M | -44.37%-50.99M | -3.76%-34.16M | -23.03%-30.18M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 16.14%-134.85M | 35.87%-29.16M | 39.78%-30.71M | -15.34%-39.4M | -17.88%-35.58M | -30.23%-160.81M | -48.07%-45.47M | -44.37%-50.99M | -3.76%-34.16M | -23.03%-30.18M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 16.14%-134.85M | 35.87%-29.16M | 39.78%-30.71M | -15.34%-39.4M | -17.88%-35.58M | -30.23%-160.81M | -48.07%-45.47M | -44.37%-50.99M | -3.76%-34.16M | -23.03%-30.18M |
| Basic earnings per share | 31.02%-2.58 | 40.22%-0.55 | 53.23%-0.58 | 9.52%-0.76 | 4.05%-0.71 | -23.43%-3.74 | -22.67%-0.92 | -42.53%-1.24 | -3.70%-0.84 | -23.33%-0.74 |
| Diluted earnings per share | 31.02%-2.58 | 40.22%-0.55 | 53.23%-0.58 | 9.52%-0.76 | 4.05%-0.71 | -23.43%-3.74 | -22.67%-0.92 | -42.53%-1.24 | -3.70%-0.84 | -23.33%-0.74 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025